Clinical Trial Update: Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating certolizumab pegol added to methotrexate versus methotrexate alone in rheumatoid arthritis has completed, with results assessing effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: UCB Pharma | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED